Art Unit 1633
Group 1630Stem Cells and Nucleic Acid Related Therapy
- Active examiners
- 33
- Average office actions per grant
- 2.36
Grant ratio
- Art Unit 1633
- 47.5%
- Group 1630
- 52.0%
Active examiners
| Ileana Popa | 18.4% | 3.52 | August 2026 |
|---|---|---|---|
| Maria Marvich | 49.2% | 2.93 | August 2026 |
| Robert M Kelly | 71.5% | 1.97 | August 2026 |
| Michael Burkhart | 59.4% | 1.95 | August 2026 |
| Kevin K. Hill | 35.9% | 2.40 | July 2026 |
| Anne Marie S. Wehbé, Ph.D | 56.5% | 2.60 | August 2026 |
| Quang Nguyen, Ph.D | 36.0% | 2.80 | August 2026 |
| Kimberly A Aron | 48.3% | 2.34 | August 2026 |
| Arthur S Leonard | 49.6% | 2.60 | August 2026 |
| E. Yvonne Pyla | 48.3% | 2.80 | August 2026 |
| Allison M Fox | 59.8% | 2.13 | August 2026 |
| Jennifer S Spence | 32.6% | 2.17 | August 2026 |
| Alyssa G Weston | 31.1% | 2.15 | August 2026 |
| Dr. Alexander Nicol | 39.9% | 2.98 | August 2026 |
| Qinhua Gu | 31.5% | 1.49 | August 2026 |
| Hanan Isam Abuzeineh | 32.4% | 2.29 | July 2026 |
| Joel D Levin | 18.4% | 2.11 | August 2026 |
| Masudur Rahman | 17.2% | 2.09 | August 2026 |
| Jagamya Vijayaraghavan | 12.4% | 1.18 | August 2026 |
| Katherine R Small | 32.1% | 1.52 | August 2026 |
| Gina Pronzati | 10.9% | 1.29 | August 2026 |
| James J Graber | 38.7% | 2.15 | August 2026 |
| Marisol A O'Neill | 0.0% | N/A | August 2026 |
| Caroline M Lara | 0.0% | N/A | August 2026 |
| Christopher M. Babic | 6.7% | 2.06 | August 2026 |
| Dr. Katie L Pennington | 17.4% | 1.63 | August 2026 |
| Joseph T Woitach | 0.0% | 2.89 | August 2026 |
| Michael A Riga | 25.0% | 2.37 | August 2026 |
| Thomas Russe Amick | 75.0% | 2.28 | August 2026 |
| Vyoma Shubham Tiwari | 20.0% | 2.43 | August 2026 |
| Brendan Thomas Tinsley | 44.4% | 2.40 | August 2026 |
| Liliana Cerullo | 0.0% | 1.00 | July 2026 |
| Jianjian Zhu | 0.0% | 2.09 | August 2026 |
Examiner distribution
- Median grant ratio
- 32.5%
- Middle 50% of grant ratios
- 17.6%–48.3%
- Median office actions / grant
- 2.15
- Middle 50% of office actions / grant
- 1.96–2.60
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Janet Epps-Smith | 51.5% | 2.65 | April 2026 Potentially inactive |
|---|---|---|---|
| Maria Leavitt | 61.5% | 2.36 | January 2026 Appears inactive |
| Scott Long | 74.4% | 1.96 | January 2023 Appears inactive |
| James D. (Doug) Schultz, Phd | 59.5% | 2.18 | February 2026 Appears inactive |
| Q. Janice Li | 65.6% | 1.89 | September 2018 Appears inactive |
| Examiner Kelaginamane Hiriyanna Ph.D | 33.1% | 3.41 | December 2017 Appears inactive |
| Fereydoun G. Sajjadi | 46.2% | 1.56 | February 2026 Appears inactive |
| Sumesh Kaushal | 58.5% | 1.29 | November 2011 Appears inactive |
| Anjeanette Roberts | 54.8% | 1.41 | September 2022 Appears inactive |
| Thomas J Raborg | 0.0% | N/A | December 2020 Appears inactive |
Based on available public USPTO records; may be incomplete.